|
Symptoms
Chronic
Fatigue Syndrome-Myalgic Encephalomyelitis (ME) is characterized by
a severe, prolonged fatigue lasting for more than six months. Patients
complain of extreme exhaustion; they tire easily in the course of normal
activities, and may even be unable to perform normal tasks. Fatigue
is accompanied by a number of other symptoms: neurocognitive impairments
(memory loss, difficulty in concentrating), muscle pain, headaches,
unrefreshing sleep, sore throat, persistent low grade fever, enlarged
lymph nodes. ME shares overlapping symptomology with several diseases.
Before making a diagnosis of ME, other specific illnesses in which fatigue
is the core symptom (such as hypothyroidism, anemia, Lyme disease, lupus,
diabetes, cancer…) must be excluded. The disease is also known as post-viral
fatigue syndrome or chronic fatigue and immune dysfunction syndrome
(CFIDS).
Prevalence
and economical cost
ME
affects between 0.2 and 0.5 percent of the population (approximately
one million people affected in the USA, and two million in Europe).
Anybody can get ME, however women are affected more frequently than
men by a ratio of 4:1. The most common age of onset is between 20 and
40 years. ME can also occur in children and adolescents. The annual
socio-economic costs of ME (direct and indirect) have been estimated
at $16 billion in the USA, and €20 billion in Europe.
Opportunistic
infections in ME
Dysregulations
of the immune system in ME patients (depressed NK and T cells, chronic
inflammation) favor the development of opportunistic infections such
as mycoplasma, chlamydiae, or viral reactivations. Viruses frequently
found in ME patients include herpesviruses (HHV-6, Epstein-Barr Virus,
Cytomegalovirus) but also enteroviruses and parvovirus B19. All these
viruses are found at high titers in the gastro-intestinal mucosa of
the patients.
|
Intestinal
dysfunctions in ME
Intestinal
dysfunction is a characteristic of ME. A frequent disorder is dysbiosis,
i.e. the overgrowth of pathogenic bacteria in the intestine. The adult
human intestinal tract is estimated to contain up to 10exp14 viable
microorganisms (10 times more than the number of cells that form the
body!). Over 50 different genera of bacteria are represented, accounting
for more than 500 different species... Intestinal microflora represents
an ecosystem of the highest complexity. This microflora plays critical
roles in the digestion and absorption of nutrients, in the synthesis
of vitamins (B and K groups) and fatty acids, in the detoxification
of ingested chemicals, but also in the regulation of the immune system.
Composition
of the gut microflora can be affected by several factors including antibiotic
use, stress, and diet. Alterations of the gut microflora may have serious
consequences for the host health. Overgrown pathogenic bacteria produce
toxins and compounds that are very detrimental to intestinal cells:
for instance, sulfate-reducing bacteria produce toxic hydrogen sulfide.
Chronic
inflammation of the gut mucosa, resulting from dysbiosis, can lead to
the development of leaky gut syndrome. Leaky Gut Syndrome is a condition
in which the ability of the intestinal wall to keep out large and undesirable
molecules is reduced: substances that are normally kept within the intestines
are "leaking" across the intestinal wall. One compound that can easily
make its way to the blood is bacterial lipopolysaccharide (LPS). LPS
will induce a strong pro-inflammatory response in monocytes and macrophages,
involving recognition by a receptor (Toll-like receptor-4) and the subsequent
secretion of cytokines such as IL-1, IL-6, TNF-alpha. Environmental
toxins (food additives, pesticides, PCBs…) can also pass more easily
into the circulation, and cause damage to all organs, notably the liver
and the brain. Multiple Chemical Sensitivities may develop as the nervous
system becomes sensitized. Finally, development of food allergies and
auto-immune reactions may also occur, as undigested, large molecules
which are allowed into the bloodstream will initiate a reaction of the
immune system.
|